Bayern Leadership’s Public Criticism of Musiala Sparks Backlash from FIFPRO and AGM

FC Bayern München midfielder Jamal Musiala suffered a health relapse on Monday, his second absence since August. The setback occurred following a medication adjustment, according to details reported by ran.

Contract value under pressure

While the player’s camp views these hurdles as a necessary optimization process, the frequency of his absences has triggered intense scrutiny from club leadership. Musiala’s current contract, which runs through 2030, is valued at approximately 25 million euros per year plus bonuses.

Management is now questioning whether the midfielder can regain his previous form. Following Friday’s 1-1 draw against 1. FC Köln, supervisory board member Karl-Heinz Rummenigge suggested that the club may need to revisit those financial terms.

“What we know unfortunately suggests it will be difficult to reach the level he has shown so often in this stadium,” Rummenigge said to Sky.

These remarks mirror concerns previously voiced by honorary president Uli Hoeneß and CEO Jan-Christian Dreesen. According to ran, these public statements were deliberate; the board convened on Monday evening—the same day as the latest incident—to discuss his future.

Clashing views on recovery

The divide between the club and Musiala’s representatives is widening. Executives fear the required medication could permanently cap his athletic output, while his camp insists the condition is manageable.

The tension spilled into the open during Saturday’s annual general meeting at BMW Park. Dr. Jonatan Hoffmann, a neurologist and Bayern supporter, took the board to task for their public rhetoric.

“In such a situation one needs support, just as Jamal Musiala has received from Max Eberl and Vincent Kompany,” Hoffmann said, according to ran.

FIFPRO condemns club strategy as bargaining tactic

FIFPRO, the international players' union, condemned the club's strategy, describing the public comments as a coordinated effort to gain bargaining power in contract talks. The union argued that the club has a duty of care to handle such discussions behind closed doors.

Club president Herbert Hainer attempted to de-escalate the situation at the general meeting, asserting that the organization remains fully supportive of the player. Hainer said that he does not believe the club, or Musiala himself, was aware of the neurological condition when the contract was signed in February 2025.

Dreesen also softened his tone, telling attendees that the board had no intention of pressuring the player.

“He needs the time to come back. We have said that several times now. He must get that. And then we will see how things look at the beginning of next year,” Dreesen said.

It is not yet known how the player’s medical team plans to adjust the treatment regimen or whether he will be cleared to return to training before the year ends.

Photo of author

Newsroom

Newsroom at Archyde.

How to Watch Saints vs. Bears: TVNZ+ VPN, Kickoff Time, and Week 11 Preview